InvestorsHub Logo
Followers 971
Posts 383010
Boards Moderated 6
Alias Born 06/24/2011

Re: None

Thursday, 06/27/2019 9:01:36 AM

Thursday, June 27, 2019 9:01:36 AM

Post# of 303
grabbed this from the news: Dr. Weglicki commented, "We look forward to investigating the efficacy of this promising therapy that targets the side effects of cutaneous toxicity due to some anticancer drugs. Our investigators at GW anticipate productive future collaborations with Hoth's innovative scientific research team. These synergistic efforts will concentrate on treatment of dermatological side effects, some of which may be so severe that many patients may choose to discontinue potentially life-prolonging cancer drug therapy."

$HOTH
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HOTH News